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phone calls following the collision; however, she became non-
responsive a short time later. Patient was transported to an outside
hospital, had a tonic-clonic seizure, was intubated, and then trans-
ferred to Children’s Hospital of Wisconsin. Computed tomography
(CT) of head revealed a left frontotemporal skull fracture and large
heterogeneous left frontal mass with calcification and hemorrhagic
transformation. Subsequent magnetic resonance imaging (MRI) of
brain revealed a large (8.3x7 cm), lobulated, avidly enhancing,
extra-axial heterogeneous mass that appeared consistent with a
meningioma. Within 10 hours of admission, intravenous epineph-
rine was initiated to maintain cerebral perfusion and blood pres-
sures.
Setting: Pediatric hospital.
Results or Clinical Course: Patient extubated on hospital day 3
and progressed well in physical and occupational therapy. She was
discharged home on hospital day 5 without significant cognitive or
functional deficits. She returned 2 months later, once fully recov-
ered, for tumor resection, with pathology consistent with meningi-
oma.
Discussion: This is the first reported case, to our knowledge, of a
meningioma bleed secondary to a traumatic brain injury. The pa-
tient’s underlying brain pathology may have predisposed her to
hemorrhage and led to a more significant degree of brain injury.
Conclusions: The mass effect from brain tumors like meningio-
mas are known to cause cognitive and functional deficits. Although
meningiomas are slow growing and considered relatively benign,
this case illustrates the potential acute complications of trauma in a
patient with meningiomas.
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Objective: Evaluation of prevalence of tracheostomy and gastros-
tomy tube use in the pediatric population in patients being treated
for traumatic brain injury. Design: A retrospective chart review of
patients aged 3-18 being treated for acute traumatic brain injury and
hemorrhage on imaging.
Setting: A local pediatric hospital.
Participants: 115 patients aged 3-18 with acute traumatic brain
injury.
Interventions: Placement of a tracheostomy and/or a gastrostomy
tube. Main Outcome Measures: Each case was evaluated for the use
of a tracheostomy and/or gastrostomy tube placement and corre-
lated with the severity of traumatic brain injury. Additionally, the
amount of time in relation to utilization of tracheostomy or gastros-
tomy was evaluated in comparison to the amount of inpatient
hospital days.
Results: The overall prevalence of gastrostomy tube placement in
the acute traumatic brain injury population studied was 9.6%;
however, the placement of tracheostomy tube placement was 7.8%.
Both were found to be associated with a severe Glasgow Coma Scale
(GCS) of 8 or below (P.014) and this population had a higher
utilization percentage than those patients with mild or moderate
GCS. Average time from admission to placement of gastrostomy and
tracheostomy tube placement was 11.6 and 10.3, respectively.
There was also a statistically significant (P .05) difference in the
number of acute inpatient hospital days between those who did not
receive a gastrostomy or tracheostomy tube (5.5 days) and those
who received both (20 days). Gastrostomy and tracheostomy tube
placement was also found to be statistically associated with transfer
to an inpatient rehabilitation facility.
Conclusions: Pediatric patients with acute severe GCS were
more likely to require a gastrostomy and tracheostomy tube. These
patients also had longer inpatient hospital stays and were more
likely to be transferred to an acute inpatient rehabilitation facility.
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Case Description: We report on two patients with previously
diagnosed cerebral palsy (CP), both premature infants, with novel brain
neoplasms found incidentally on neuro-imaging. Patient A received
computed tomography (CT) of the head to assess for mastoiditis in the
setting of suppurative otitis media and a craniopharyngioma was noted.
Retrospective analysis demonstrated the presence of the craniopharyn-
gioma on previous imaging. Patient B was non-verbal, but was noted by
her mother to be crying. Head CT was done to rule out ventriculoperi-
toneal shunt malfunction, which demonstrated an expansile left-sided
acoustic neuroma. Retrospective analysis of 5 previous head CT scans
demonstrated the presence of this neoplasm 7 years prior but the
finding was not addressed in the radiology report.
Setting: Tertiary care pediatric hospital.
Results or Clinical Course: Both patients underwent resection.
Discussion: Brain tumors are the most common solid neoplasms
in childhood and they are a rare cause of CP when diagnosed in
infancy, subsequently causing motor disability. However, the inci-
dence of brain tumors in children with CP where the tumor is
seemingly unrelated to the motor disability has not been described
in the literature. Children with CP tend to receive neuroimaging
more frequently than the general population, but these frequent
studies may actually contribute to missed findings as the reader is
directed toward a specific question and fails to see the tumor.
Close attention must be paid to ensure this patient population
receives the same thorough consideration for their scans, just as
children without a neurologic disability.
Conclusions: A previously diagnosed brain anatomy abnormal-
ity may obscure the identification of new abnormalities such as
brain neoplasms.
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Case Description: The patient underwent 35 days of induction
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chemotherapy by COG-AALL 0932 protocol that included intravenous
vincristine on day(s) 1, 8, 15 and 22 and intrathecal methotrexate on
day(s) 8 and 29. On day 23 he developed rapidly progressive bilateral
leg pain and weakness which led to hospital admission on day 27. By
day 29 he could no longer ambulate. Magnetic resonance imaging
(MRI) with gadolinium contrast was performed on day 40 which
showed symmetric ventral rootlet enhancement from T12 through the
sacral levels. A lumbar puncture on day 41 showed elevation in cerebral
spinal fluid (CSF) protein.
Program Description: Five-year-old previously healthy boy
with newly diagnosed standard risk acute lymphocytic leukemia
(ALL).
Setting: Tertiary care pediatric hospital.
Results or Clinical Course: On the day of admission (day 42)
his physical examination was notable for flaccid paralysis in the
lower extremities, poor trunk and head control, distal upper ex-
tremity weakness and absent deep tendon reflexes. An electromyog-
raphy study (EMG) performed on day 43 showed severely dimin-
ished muscle action potential amplitudes at the median and ulnar
nerves and absent at the peroneal nerve. F waves were absent due to
low amplitudes. On needle examination there was absent motor
unit recruitment in the vastus medialis. He was then administered
intravenous immunoglobulin (IVIG) 2 g/kg over 5 days with little
clinical improvement. An anti-ganglioside antibody panel was neg-
ative. His motor examination and medical condition stabilized and
he was enrolled in inpatient rehabilitation on day 53. He completed
a 78-day acute rehabilitation course with modest improvement in
trunk control and pinch strength but persistent flaccid lower ex-
tremity paralysis.
Discussion: There are numerous reports regarding neuropathy
after intravenous vincristine administration. This neurotoxicity can
result in symptoms ranging from mild to severe. In instances of
severe impairment from axonal degeneration the electromyography
pattern has been reported as a mixed motor and sensory axonal
neuropathy. We believe this is the first case report of an isolated
acute motor axonal neuropathy temporally related to vincristine
administration.
Conclusions: Acute motor axonal neuropathy is a rare but seri-
ous potential adverse effect after chemotherapy with intravenous
vincristine administration.
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Case Description: Patient: A 10-year-old boy with mixed tone
quadriplegic cerebral palsy (CP).
Setting: Tertiary care pediatric rehabilitation hospital.
Results or Clinical Course: The patient presented due to
concerns of a malfunctioning intraventricular baclofen pump with
worsening tone despite increased intraventricular dose to nearly
2000 mcg/day, oral baclofen, and valium. He was found to have
hydrocephalus for which a ventriculoperitoneal shunt was placed.
In addition, the intraventricular baclofen catheter was removed and
one placed intrathecally. The procedure was characterized by sig-
nificant difficulty threading the catheter into the intrathecal space
requiring several attempts. Immediately post-operatively, tone was
well controlled with a lower intrathecal baclofen (ITB) dose (800
mcg/day); however, he required further dose adjustments to 1800
mcg/day flex dosing in addition to oral tizanidine and valium with
poor tone control, raising concerns for catheter malfunction. A dye
study was terminated early due to difficulty aspirating from the
catheter access port. A computed tomography (CT) myelogram
revealed the catheter entering the spine epidurally at the lumbar
level and threaded up to the thoracic spine in the epidural space.
Revision of the ITB catheter was done via lumbar laminectomy to
verify intrathecal placement. ITB dose was 650 mcg/day simple
continuous at the time of discharge with much better tone control.
Discussion: Although there have been few cases reported of cath-
eter tip migration into the epidural space, this is the first reported
case, to our knowledge, of ITB complications from epidural place-
ment of the intrathecal baclofen catheter in a child with CP. Epidu-
ral catheter tip is ineffective as baclofen does not cross the dura.
Conclusions: Epidural catheter placement must be considered in
failure of ITB therapy in a patient with a newly replaced catheter
with a history of difficult catheter placement.
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Objective: To determine if more microdissection or higher per-
centage of sensory rootlets sectioned during selective dorsal rhizo-
tomy (SDR) results in increased likelihood of dysesthesias.
Design: Retrospective cohort.
Setting: Tertiary care center.
Participants: 99 children with cerebral palsy (CP) who under-
went SDR between 2000 and 2010.
Interventions: None. Main Outcome Measures: Data were ex-
tracted including demographics, CP subtype, Gross Motor Func-
tional Classification Scale (GMFCS) level, total number of rootlets
assessed and percentage of rootlets cut, incidence and duration of
dysesthesias, gabapentin use, and length of stay. Logistic regression
model was used to analyze the collected data.
Results: Total incidence of dysesthesias was 41.4%: 15.0% for
2000-2005, and 59.3% for 2006-2010. There was no association of
dysesthesia with gender, age, GMFCS level or CP subtype. The
number of rootlets in the microdissection and the total percentage of
rootlets cut were not associated with dysesthesias. Gabapentin was
used in 97.1% of cases during 2006-2010. Symptoms resolved by
the time of discharge in 75%. Dysesthesias did not impact length of
stay.
Conclusions: The reported incidence of altered sensation after
SDR varies from 2-40%, but no studies have addressed the occur-
rence of dysesthesias. In our retrospective chart review, the inci-
dence of dysesthesias was 41.4% overall. An increased incidence
was noted in the 2006-2010 time period, likely a result of our
heightened awareness of this potential complication. There was no
association with gender, age, GMFCS level or CP subtype, poten-
tially because the children for whom SDR is the recommended
treatment at our institution are relatively homogeneous. There was
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